Expression and prognostic significance of centromere protein A in human lung adenocarcinoma

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 407-414

  Wu, Qing ^a   Qian, Yi Ming ^b   Zhao, Xiang Li ^b   Wang, Shou Mei ^b   Feng, Xiao Jun ^b   Chen, Xin Fang ^c   Zhang, Shu Hui ^b  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Centromere protein A; Immunohistochemistry; Lung adenocarcinoma; Prognostic factor

Indexed keywords

CENTROMERE PROTEIN A; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL PREDICTION; SURVIVAL TIME; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AUTOANTIGENS; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84863775729     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.04.007     Document Type: Article

References (30)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Herbst R.S., Heymach J.V., Lippman S.M. Lung cancer. N Engl J Med 2008, 359:1367-1380.
3. Omlin A., D'Addario G., Gillessen S., Cerny T., von Hessling A., Fruh M. Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung. Lung Cancer 2009, 65:383-384.
4. Yatabe Y., Borczuk A.C., Powell C.A. Do all lung adenocarcinomas follow a stepwise progression?. Lung Cancer 2011, 74:7-11.
5. Ladanyi M., Pao W. Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 2008, 21(Suppl. 2):S16-S22.
6. Fang X., Zhang P. Aneuploidy and tumorigenesis. Semin Cell Dev Biol 2011, 22:595-601.
7. Yuen K.W., Montpetit B., Hieter P. The kinetochore and cancer: what's the connection?. Curr Opin Cell Biol 2005, 17:576-582.
8. Black B.E., Jansen L.E., Maddox P.S., Foltz D.R., Desai A.B., Shah J.V., et al. Centromere identity maintained by nucleosomes assembled with histone H3 containing the CENP-A targeting domain. Mol Cell 2007, 25:309-322.
9. Li Y., Zhu Z., Zhang S., Yu D., Yu H., Liu L., et al. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth. PLoS One 2011, 6:e17794.
10. Tomonaga T., Matsushita K., Yamaguchi S., Oohashi T., Shimada H., Ochiai T., et al. Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res 2003, 63:3511-3516.
11. Liao W.T., Wang X., Xu L.H., Kong Q.L., Yu C.P., Li M.Z., et al. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer 2009, 115:1507-1517.
12. Travis W.D., Brambilla E., Muller-Hermelink E.H.K. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon, p. 35-44.
13. Sobin L., Gospodarowicz M., Wittekind C. TNM classification of malignant tumours 2009, Wiley-Liss Inc, New York, 138-146. 7th ed.
14. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
16. Zhu Z., Luo Z., Li Y., Ni C., Li H., Zhu M. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 2009, 49:504-512.
17. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
18. Zhang S.H., Qian Y.M., Liu A.W., Cai J., Zhao X.L., Wei J.J. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Hum Pathol 2012, 10.1016/j.humpath.2011.08.019.
19. Ricke R.M., van Deursen J.M. Correction of microtubule-kinetochore attachment errors: mechanisms and role in tumor suppression. Semin Cell Dev Biol 2011, 22:559-565.
20. Sugata N., Li S., Earnshaw W.C., Yen T.J., Yoda K., Masumoto H., et al. Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere-kinetochore complexes. Hum Mol Genet 2000, 9:2919-2926.
21. Tomonaga T., Matsushita K., Ishibashi M., Nezu M., Shimada H., Ochiai T., et al. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res 2005, 65:4683-4689.
22. Okada M., Okawa K., Isobe T., Fukagawa T. CENP-H-containing complex facilitates centromere deposition of CENP-A in cooperation with FACT and CHD1. Mol Biol Cell 2009, 20:3986-3995.
23. Okada M., Cheeseman I.M., Hori T., Okawa K., McLeod I.X., Yates J.R., et al. The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol 2006, 8:446-457.
24. Suzuki H., Kawaguchi T., Hasegawa T., Yonechi A., Ohsugi J., Higuchi M., et al. Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma. Cancer Lett 2006, 237:242-247.
25. Yoo S.B., Chung J.H., Lee H.J., Lee C.T., Jheon S., Sung S.W. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung. J Thorac Oncol 2010, 5:964-969.
26. Ladelfa M.F., Toledo M.F., Laiseca J.E., Monte M. Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production. Antioxid Redox Signal 2011, 15:1749-1761.
27. Chari N.S., Pinaire N.L., Thorpe L., Medeiros L.J., Routbort M.J., McDonnell T.J. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death. Apoptosis 2009, 14:336-347.
28. Oikawa T., Okuda M., Ma Z., Goorha R., Tsujimoto H., Inokuma H., et al. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1. Mol Cell Biol 2005, 25:4046-4061.
29. Maehara K., Takahashi K., Saitoh S. CENP-A reduction induces a p53-dependent cellular senescence response to protect cells from executing defective mitoses. Mol Cell Biol 2010, 30:2090-2104.
30. Mitsudomi T., Hamajima N., Ogawa M., Takahashi T. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000, 6:4055-4063.